GlassScriptPhysician profile
Brian J Mattison
NPI 1407384688
$6,100.37
in general payments reported to CMS, 2019-2025
17 companies · $2,430 in 2025
The $2,430 reported for 2025 was more than what 92% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.00 · 2020: $13.35 · 2021: $474 · 2022: $1,544 · 2023: $494 · 2024: $1,071 · 2025: $2,430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,027 · Food and Beverage: $1,968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,026.65 |
| Food and Beverage | $1,967.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Voom Medical Devices, INC. | $1,768.56 | 2025 | Revcon Instrument Kit, Sterile |
| Southern Edge Orthopaedics, INC. | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $825.17 | 2019-2025 | Collagenase Santyl, Acticoat 4" X 4", Versajet |
| Stryker Corporation | $820.04 | 2022-2024 | Prostep, Anchorage, Hoffmann |
| Treace Medical Concepts, INC. | $439.94 | 2022-2025 | |
| Linvatec Corporation | $295.56 | 2024 | Biobrace 23mm |
| Amgen INC. | $149.50 | 2025 | Krystexxa |
| Acera Surgical, INC. | $137.53 | 2025 | Restrata Wound Matrix |
| Abbott Laboratories | $127.75 | 2025 | Esprit |
| Horizon Therapeutics Plc | $117.14 | 2021 | |
| Stability Biologics, LLC | $51.84 | 2025 | |
| Nevro Corp. | $43.01 | 2023 | Senza |
| Trice Medical, INC. | $41.69 | 2025 | |
| Nabriva Therapeutics, Plc | $34.17 | 2021-2022 | |
| Medtronic, INC. | $21.93 | 2023 | Intellis Adaptivestim |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $14.39 | 2023 | |
| Biotissue Holdings INC. | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mattison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.